DR. SHYAM SUNDER PANCHOLI

@pharmacy-shirpur.nmims.edu

Professor and Associate Dean, School of Pharmacy & Technology Management, SVKM's NMIMS, Shirpur Campus
School of Pharmacy & Technology Management, SVKM's NMIMS, Shirpur Campus

DR. SHYAM SUNDER PANCHOLI


                        Download Compact PDF  
https://researchid.co/sspancholi
Dr. Pancholi, Associate Dean SPTM- NMIMS has a blend of industrial, academic and research experience exceeding 28 years. He is in Pharmacy teaching profession since 1997 and has worked in different capacities contributing to syllabus design, quality teaching and accreditation processes. He also worked for industry in various sections like- packaging, oral powders, tablets, coating, oral liquids, capsules and parenteral and lead the team for ISO and GMP certification. He guided 28- B.Pharm 10 Pharm.D projects; 35- M. Pharm. and 18- Ph.D, thesis. He has undertaken several industrial, research and consultancy projects and grants from private and government funding agencies. He has to his credit 2 Indian Patents, 2 design patents 101 articles, 4 books 4 chapters, and 48 presentations and 21 invited lectures in conferences. He is on Editorial /advisory board of scientific journals of repute and is active life member of IPA APTI, ICS and SPER. His interest includes- F&D, RA, Analysis, QA.

EDUCATION

Degree Institute/ University Year Percentage Special Remarks
B.Pharm. B.N. College, Rajasthan 1993 74% Univ. 1st (Gold Medal)
M.Pharm L.M. College, Gujarat University 1995 62.5% Univ. First (Q.A.)
L.L.B. Faculty of Law, JNV University 2002 63% 4th Rank in University
Ph.D Dr. H.S. Gaur University, Sagar Feb. 2005 - PHARMACEUTICS
PGDIPR I.G.N.O.U Jun 2010 BB grade Correspondence
GCIP WIPO, Academy Geneva April 2010 77% Distance Learning

RESEARCH, TEACHING, or OTHER INTERESTS

Analytical Chemistry, Pharmacy
54

Scopus Publications

2303

Scholar Citations

23

Scholar h-index

37

Scholar i10-index

Scopus Publications

  • Design and Development of Chitosan-Based Posaconazole Loaded Dry Powder by Using BBD
    Sushil Kumar Singh, Shyam Sunder Pancholi
    Indian Journal of Pharmaceutical Education and Research, 2026
  • Optimizing Chitosan-based Posaconazole Dry Powder Formulation Using Box-Behnken Design: The Role of Leucine in Enhancing Performance
    Sushil Kumar Singh, Shyam Sunder Pancholi
    Infectious Disorders Drug Targets, 2026
    Introduction: The objective of this study was to develop and optimize a dry powder inha-lation formulation of Posaconazole-loaded Chitosan Nanoparticles (POS-CSNPs) using a Quality by Design (QbD) approach. The aim was to enhance pulmonary drug delivery and antifungal efficacy, particularly against Rhizopus oryzae, by improving drug encapsulation, particle dispersion, and lung deposition using leucine as a performance enhancer. Methods: A Box-Behnken Design (BBD) was employed to evaluate the effects of Chitosan-to-Tripolyphosphate (CS:TPP) ratio, stirring speed, and polymer concentration on particle size, Poly-dispersity Index (PDI), and Entrapment Efficiency (EE). Nanoparticles were prepared via ionic gela-tion and spray-dried with varying concentrations of lactose and leucine. Characterization techniques included FTIR for drug-excipient compatibility, Dynamic Light Scattering (DLS) for size and zeta potential, TEM for morphology, and XRD for crystallinity. In vitro drug release, pulmonary deposi-tion using a twin-stage impinger, antifungal activity, and stability under ICH conditions were as-sessed. Results: The optimized formulation had a particle size of 248.20 ± 6.82 nm, PDI of 0.225 ± 0.010, zeta potential of 21.92 ± 0.84 mV, and EE of 68.17 ± 1.73%. In vitro release showed sustained drug delivery over 48 hours. The Fine Particle Fraction (FPF) reached 68.9% in leucine-based formula-tions, and antifungal activity was significantly higher compared to the pure drug, with a zone of inhibition of 21 ± 0.5 mm. Discussion: The results demonstrated improved particle characteristics, drug release, and antifungal efficacy. Leucine significantly enhanced dispersibility and deposition. However, scale-up and batch consistency remain challenges. Further in vivo studies are needed to confirm clinical applicability. Conclusion: The study successfully developed a stable, effective dry powder POS-CSNP formulation with enhanced pulmonary delivery and antifungal activity, offering potential for improved treatment of pulmonary fungal infections.
  • Formulation and Evaluation of Microsphere Drug Delivery System for Anti-Hypertensive Drug
    Komal K Raval, Shyam Sunder Pancholi
    Research Journal of Pharmacy and Technology, 2026
    Ethyl cellulose and Eudragit RL – 100-based sustained release hydralazine hydrochloride microspheres with a lower dosing frequency were the focus of this study. Materials and Methods: The Hydralazine Hydrochloride -loaded microspheres were formulated by Non-Aqueous Solvent Evaporation Method. A 32 factorial design was employed to study the influence of drug: Polymer ratio on percentage entrapment Efficiency, particle size, and % Yield. Results: The entrapment efficiency was found to be 85.34%, %yield 79.8% and particle size 200μm. Conclusions: Drug: Polymer ratio had significant effect on % entrapment efficiency, particle size, and % yield. The Prepared Microspheres can also be incorporated in Capsule, Transdermal patch, gel and other suitable Dosage forms to obtain the Desired therapeutic Effects. The Prepared Formulation will be more Patient Compliance compared to other Standard Dosage forms for Antihypertensive medication available in market.
  • Recent Approach for an Effective Treatment of Mucormycosis and Future Directions
    Sushil Kumar Singh, Md Moidul Islam, Shyam Sunder Pancholi
    Anti Infective Agents, 2026
    Mucormycosis is an aggressive and often fatal fungal infection, posing a significant challenge in immunocompromised patients, particularly those with diabetes, cancer, or postorgan transplantation. Despite available antifungal treatments such as amphotericin B, posaconazole, and isavuconazole, mortality rates remain high, highlighting the need for early diagnosis and aggressive intervention. This review explores current therapeutic strategies, including antifungal therapy, and the critical role of surgical intervention in improving outcomes. Additionally, it examines innovative drug delivery systems, such as nanoparticle-based formulations and liposomal encapsulation, designed to enhance drug efficacy while minimizing toxicity. The recent surge in mucormycosis cases, particularly during the COVID-19 pandemic, emphasizes the urgent need for improved awareness, early detection, and optimized treatment protocols. Advancements in diagnostic techniques and emerging therapeutic approaches offer hope for better management of this deadly infection. By analyzing current trends and future directions, this article advocates for a multidisciplinary approach that combines clinical expertise with cutting-edge research. Strengthening collaborative efforts in diagnosis, treatment, and drug development is essential to reducing mortality and improving patient outcomes in this rare but life-threatening disease.
  • Next Generation Technologies for Sustainable Development
    Sunita R Patil, Shyam S. Pancholi, Girdhari Lal Gupta, Preeti C. Sangave
    Next Generation Technologies for Sustainable Development, 2026
  • Preface
    Next Generation Technologies for Sustainable Development, 2026
  • Advanced Relationships Between Structure and Properties of Chitosan-Based Polymeric Hydrogels in Oncology and Their Impact on the Tumor Microenvironment
    Sankha Bhattacharya, Dilpreet Singh, Amit Page, Mayank Sharma, Rahul Maheshwari, Shyam Sunder Pancholi
    Journal of Macromolecular Science Part B Physics, 2026
  • Role of Posaconazole Drug in the Treatment of Invasive Fungal Disease: A Review
    Sushil kumar Singh, Shyam Sundar Pancholi
    Infectious Disorders Drug Targets, 2025
    Posaconazole is an antifungal medication used primarily to treat invasive fungal infections caused by various organisms, such as Aspergillus, Candida, and certain molds. It belongs to the class of drugs known as triazole antifungals. Clinical studies have reported posaconazole to be effective in treating various invasive fungal infections, especially in patients who are immunocompromised, such as those with weakened immune systems due to conditions like HIV/AIDS, undergoing chemotherapy, or having received an organ transplant. It has effectively treated invasive candidiasis, aspergillosis, zygomycosis, and other serious fungal infections. The effectiveness of the drug varies based on factors, such as the type of infection, the patient's immune status, and the site of infection. This review describes the types of infection, the drug's safety profile, the development of resistance to posaconazole, and strategies to manage or prevent resistance.
  • Current Updates on Pathogenesis, Systemic Therapy, and Treatment of Invasive Fungal Infections
    Sushil Kumar Singh, Shyam Sunder Pancholi
    Current Drug Targets, 2025
    Numerous health hazards are associated with fungal infections, ranging from asymptomatic cases to potentially fatal invasive diseases that are especially dangerous for those with impaired immune systems. The main causes behind these diseases are opportunistic fungi, namely <i>Aspergillus, Candida</i>, and <i>Cryptococcus</i>. Invasive fungal infections (IFIs) require a global response that includes the development of vaccines, standardized protocols for diagnosis, potent antifungal medications, and strategies to stop drug-resistant strains. Improving high-risk group diagnosis and treatment is essential to lowering death rates. This review highlights the substantial health concerns associated with fungal infections, especially in immunocompromised individuals, and identifies <i>Aspergillus, Candida</i>, and <i>Cryptococcus</i> as the main pathogens. It highlights the necessity of international efforts, such as the development of novel diagnostic instruments, imaging methods, and antifungal drugs, to combat these invasive infections. The review also addresses the increasing need for novel treatment approaches in light of the developing resistance to widely used antifungal medications. Furthermore, the significance of secretory proteins in fungal pathogenicity and the potential of combination therapy are investigated. It is also suggested that a multimodal strategy be used to fight these illnesses, given the promise of multivalent vaccinations. Overall, this study emphasizes how critical it is to develop better diagnostic and treatment strategies in order to successfully control and lessen the impact of invasive fungal diseases on the health of the world.
  • In Vitro Drug Release Testing Method For Nepafenac Ophthalmic Suspension
    Pawan Kumar Gupta, Shyam Sunder Pancholi, Prasanta Das
    Journal of Pharmaceutical Sciences, 2024
  • Nanocarrier-based Targeted Delivery in Cancer
    Nanoparticles and Nanocarriers Based Pharmaceutical Freparations, 2022
  • Evaluation of depression, anxiety, and stress among university healthcare students
    Rina Tripathi, Saad S. Alqahtani, Abdulkarim M. , Meraya, Hafiz A. Makeen, Pankaj Tripathi, Shyam Sunder Pancholi
    Journal of Applied Pharmaceutical Science, 2022
  • Wound-healing and cytokine-modulating potential of medicinal oil formulation comprising leaf extract of Murraya koenigii and olive oil
    S. S. Moni, P. Tripathi, M. Sultan, S. Alshahrani, S. Alqahtani, O. Madkhali, M. Bakkari, S. Pancholi, M. E. Elmobark, A. Jabeen, S. Sanobar, M. Ashafaq, Masood Ahmed Siddiqui
    Brazilian Journal of Biology, 2022
  • Physical characterization and wound healing properties of Zamzam water
    S. S. Moni, M. Sultan, S. Alshahrani, P. Tripathi, A. Assiri, S. Alqahtani, M. Bakkari, O. Madkhali, M. F. Alam, A. Alqahtani, R. Tripathi, S. S. Pancholi, M. Ashafaq, M. E. Elmobark
    Brazilian Journal of Biology, 2022
  • Antinociceptive Activity of the Essential Oil Formulation from the Roots of Saussaura lappa Clarks
    Siddig Ibrahim Abdelwahab, Shyam Sunder Pancholi, S. Mohan, Muhammad Hadi Sultan, P. Tripathi, S. Alshahrani, Mohammed Abdul Hakim Sidiqui, A. Farasani, Manal Mohamed Elhassan Taha
    Current Topics in Nutraceutical Research, 2021
  • Asynchronous environment assessment: A pertinent option for medical and allied health profession education during the covid-19 pandemic
    Madan Mohan Gupta, Satish Jankie, Shyam Sundar Pancholi, Debjyoti Talukdar, Pradeep Kumar Sahu, Bidyadhar Sa
    Education Sciences, 2020
  • Antibacterial potential of ethanolic extract of broccoli(Brassica oleracea var. italica)against human pathogenic bacteria
    International Journal of Pharmaceutical Research, 2018
  • Prevalence of obesity and correlation with BP and diabetes: A random survey in Jazan regionof Saudi Arabia
    International Journal of Pharmaceutical Research, 2017
  • Protein binding interaction study of olmesartan medoxomil and its metabolite olmesartan by fluorescence spectroscopy
    International Journal of Pharmacy and Pharmaceutical Sciences, 2014
  • HPLC-DAD method for the pharmacokinetic interaction study of atorvastatin with pioglitazone and cholestyramine in wistar rats
    Ritesh N. Sharma
    Scientia Pharmaceutica, 2014
  • The genotoxic and cytotoxic effects of nimesulide in the mouse bone marrow
    Rina Tripathi, Pankaj Tripathi, Shyam S. Pancholi, Chhagan N. Patel
    Drug and Chemical Toxicology, 2014
  • Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: Formulation, characterization, cytotoxicity and permeability enhancement study
    Mithun Bandivadekar, Shyamsundar Pancholi, Ruchika Kaul-Ghanekar, Amit Choudhari, Soumya Koppikar
    Drug Development and Industrial Pharmacy, 2013
  • Liquid membrane phenomenon in the biological action of venlafaxine
    International Journal of Pharmacy and Pharmaceutical Sciences, 2013
  • Investigation of antimutagenic potential of Foeniculum vulgare essential oil on cyclophosphamide induced genotoxicity and oxidative stress in mice
    Pankaj Tripathi, Rina Tripathi, Rakesh K. Patel, Shyam S. Pancholi
    Drug and Chemical Toxicology, 2013
  • Lecithin- cholesterol bio- membranes and their correlation with liquid membranes
    International Journal of Pharmacy and Pharmaceutical Sciences, 2012
  • Genotoxicity of ibuprofen in mouse bone marrow cells in vivo
    Rina Tripathi, Shyam S. Pancholi, Pankaj Tripathi
    Drug and Chemical Toxicology, 2012
  • HPLC method development and validation for simultaneous estimation of Montelukast sodium and Levocetirizine dihydrochloride in pharmaceutical dosage forms
    International Journal of Pharmacy and Pharmaceutical Sciences, 2012
  • Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma
    Ritesh Sharma, Shyam Pancholi
    Acta Pharmaceutica, 2012
  • Preliminary investigation tests of novel antifungal topical aerosol
    MMonali Kapadia, ST Solanki, V Parmar, MM Thosar, SS Pancholi
    Journal of Pharmacy and Bioallied Sciences, 2012
  • Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: A delivery system for poorly water-soluble drug
    Mithun Mohanraor Bandivadeka, Shyam Sundar Pancholi, Ruchika Kaul-Ghanekar, Amit Choudhari, Soumya Koppikar
    Drug Development and Industrial Pharmacy, 2012
  • Spectrophotometric determination of Montelukast sodium and Levocetirizine dihydrochloride in tablet dosage form by AUC curve method
    Der Pharma Chemica, 2011
  • Synthesis, characterization and evaluation of antimicrobial activity of a series of 1,2,4-triazoles
    Der Pharma Chemica, 2011
  • Spectrofluorimetric determination of the H1 blocker drug levocetirizine dihydrochloride based on its oxidation with cerium (IV) in bulk and pharmaceutical formulations
    International Journal of Pharmtech Research, 2011
  • A 14-day subchronic genotoxicity study of nimesulide in mouse bone marrow cells in vivo
    Pharmacologyonline, 2011
  • Determination of suitability of polymer matrix for immobilization of enzymes
    International Journal of Pharmaceutical Research, 2011
  • Synthesis and evaluation of antitubercular activity of some thiobenzimidazolyl derivatives
    Der Pharma Chemica, 2011
  • Pharmacognostic parameters for evaluation of the rhizomes of Curcuma caesia
    Pritesh Paliwal, SS Pancholi, RakeshK Patel
    Journal of Advanced Pharmaceutical Technology and Research, 2011
  • Chronomodulated rupturable pulsatile drug delivery of theophylline: Preparation and in vitro characterization
    Latin American Journal of Pharmacy, 2010
  • Formulation and evaluation of tablets of micronized glibenclamide (Glyburide) in industrial set-up
    International Journal of Pharmaceutical Research, 2010
  • Synthesis and biological evaluation of some 2-substituted derivatives of benzimidazoles
    Journal of Pharmaceutical Sciences and Research, 2010
  • RP-HPLC-DAD method for determination of olmesartan medoxomil in bulk and tablets exposed to forced conditions
    Ritesh Sharma, Shyam Pancholi
    Acta Pharmaceutica, 2010
  • Pulsatile drug delivery for the treatment of nocturnal asthma: A chronopharmaceutical approach
    Latin American Journal of Pharmacy, 2010
  • Formulation and evaluation of timed delayed capsule device for chronotherapeutic delivery of terbutaline sulphate
    Ars Pharmaceutica, 2009
  • Validated stability indicating LC-DAD method for determination of olmesartan medoxomil in tablets exposed to stress conditions
    Acta Pharmaceutica Sciencia, 2009
  • Synthesis and antimicrobial screening of some acid chloride derivatives of 2-substituted benzimidazoles
    Oriental Journal of Chemistry, 2009
  • Microemulsion: Formulation concepts and recent applications in drug delivery
    Indian Drugs, 2009
  • Synthesis of 4-benzyl-1,3-thiazole derivatives as potential anti-inflammatory agents: An analogue-based drug design approach
    Ritesh N. Sharma, Franklin P. Xavier, Kamala K. Vasu, Subhash C. Chaturvedi, Shyam S. Pancholi
    Journal of Enzyme Inhibition and Medicinal Chemistry, 2009
  • Pair wise binding affinity: 3D QSAR studies on a set of triazolo [1, 5-a] quinoxalines as antagonists of AMPA and KA receptors.
    Ritesh N. Sharma, Hardik M. Thakar, Kamala K. Vasu, Subhash C. Chaturvedi, Shyam S. Pancholi
    Journal of Enzyme Inhibition and Medicinal Chemistry, 2009
  • Eudragit-coated pectin microspheres of 5-Fluorouracil for colon targeting
    Rania M. Hathout, Samar Mansour, Nahed D. Mortada, Ahmed S. Guinedi
    AAPS Pharmscitech, 2007
  • Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery
    Pharmazie, 2005
  • Surface-modified mesoporous ceramics as delivery vehicle for haemoglobin
    Shailendra Patil, S. S. Pancholi, S. Agrawal, G. P. Agrawal
    Drug Delivery Journal of Delivery and Targeting of Therapeutic Agents, 2004
  • Hydrotropic solubilization of nimesulide for parenteral administration
    Shikha Agrawal, S.S Pancholi, N.K Jain, G.P Agrawal
    International Journal of Pharmaceutics, 2004
  • Preparation and characterization of reverse micelle based organogels of piroxicam
    Pharmazie, 2004
  • Provesicular transdermal drug delivery system of ethinylestradiol and levonorgestrel for contraception and hormone replacement therapy
    Indian Journal of Pharmaceutical Sciences, 2003

RECENT SCHOLAR PUBLICATIONS

  • Recent Approach for an Effective Treatment of Mucormycosis and Future Directions
    SK Singh, MM Islam, SS Pancholi
    Anti-Infective Agents 24 (2), E22113525373696 , 2026
    2026
  • Current updates on pathogenesis, systemic therapy, and treatment of invasive fungal infections
    SK Singh, SS Pancholi
    Current Drug Targets 26 (3), 203-220 , 2025
    2025
    Citations: 4
  • Treatment of CNS infections in AIDS positive patients through novel drug delivery systems
    SSV Pancholi, P Saha, AS Tripathi
    Novel Drug Delivery Systems in the management of CNS Disorders, 321-331 , 2025
    2025
    Citations: 1
  • In vitro drug release testing method for nepafenac ophthalmic suspension
    PK Gupta, SS Pancholi, P Das
    Journal of Pharmaceutical Sciences 113 (4), 1061-1067 , 2024
    2024
    Citations: 8
  • Nanocarrier-based Targeted Delivery in Cancer
    SS Pancholi, A Setia, M Singhai, A Chaudhary
    Nanoparticles and Nanocarriers Based Pharmaceutical Preparations, 197-229 , 2022
    2022
    Citations: 1
  • Evaluation of depression, anxiety, and stress among university healthcare students
    R Tripathi, SS Alqahtani, AM Meraya, HA Makeen, P Tripathi, SS Pancholi
    Journal of Applied Pharmaceutical Science 12 (10), 078-087 , 2022
    2022
    Citations: 29
  • Development and Validation of RP-HPLC Method for Simultaneous Estimation of Haloperidol and Trihexyphenidyl Hydrochloride in Tablet Dosage Form
    KN Patel, UH Gajjar, PU Patel, SS Pancholi
    Asian Journal of Pharmaceutical Analysis 12 (4), 253-257 , 2022
    2022
    Citations: 2
  • Physical characterization and wound healing properties of Zamzam water
    SS Moni, MH Sultan, S Alshahrani, P Tripathi, A Assiri, SS Alqahtani, ...
    Brazilian Journal of Biology 82, e262815 , 2022
    2022
    Citations: 17
  • Wound-healing and cytokine-modulating potential of medicinal oil formulation comprising leaf extract of Murraya koenigii and olive oil
    SS Moni, P Tripathi, MH Sultan, S Alshahrani, SS Alqahtani, OA Madkhali, ...
    Brazilian Journal of Biology 82, e256158 , 2022
    2022
    Citations: 6
  • Caracterização física e propriedades cicatrizantes da água de Zamzam
    SS Moni, MH Sultan, S Alshahrani, P Tripathi, A Assiri, SS Alqahtani, ...
    Brazilian Journal of Biology 82, e262815 , 2022
    2022
  • Potencial de cicatrização de feridas e modulação de citocinas de formulação de óleo medicinal compreendendo extrato de folhas de Murraya koenigii e azeite de …
    SS Moni, P Tripathi, MH Sultan, S Alshahrani, SS Alqahtani, OA Madkhali, ...
    Brazilian Journal of Biology 82, e256158 , 2022
    2022
  • Antinociceptive Activity of the Essential Oil Formulation from the Roots of Saussaura lappa Clarks.
    SI Abdelwahab, SS Pancholi, S Mohan, MH Sultan, P Tripathi, ...
    Current Topics in Nutraceutical Research 19 (2) , 2021
    2021
    Citations: 4
  • Prevalence of stress, anxiety and depression among Pharm D students.
    R Tripathi, AA Albarraq, SS Alqahtani, P Tripathi, SS Pancholi
    International Journal of Pharmaceutical Research (09752366) 13 (1) , 2021
    2021
  • Strategic role and challenges of community pharmacists in SARS-CoV-2 outbreak
    D Talukdar, S Jankie, SS Pancholi, A Chatterjee, P Kumar, MM Gupta
    Journal of Research in Pharmacy Practice 10 (1), 1-9 , 2021
    2021
    Citations: 6
  • Asynchronous environment assessment: A pertinent option for medical and allied health profession education during the COVID-19 pandemic
    MM Gupta, S Jankie, SS Pancholi, D Talukdar, PK Sahu, B Sa
    Education Sciences 10 (12), 352 , 2020
    2020
    Citations: 93
  • Knowledge and perceptions of antimicrobial stewardship program among health-care students in Saudi Arabia
    R Tripathi, AA Albarraq, HA Makeen, SS Alqahtani, P Tripathi, ...
    Saudi Journal for Health Sciences 9 (2), 122-129 , 2020
    2020
    Citations: 8
  • Antibacterial potential of ethanolic extract of broccoli (Brassica oleracea var. italica) against human pathogenic bacteria
    J Somasundaram, SS Moni, HA Makeen, M Intakhabalam, SS Pancholi, ...
    Int J Pharm Res 10 (2), 143-146 , 2018
    2018
    Citations: 14
  • Stability testing of extemporaneous preparation of methyl salicylate ointment
    H Makeen, S Pancholi, H Alhazmi, A Ezzi, AA Hazzazi, A Meraya
    Journal of Health Specialties 6 (2), 72-72 , 2018
    2018
    Citations: 11
  • Shelf life study of extemporaneously prepared omeprazole oral suspension
    HA Makeen, SS Pancholi, MS Ali, MI Alam, MS Alam, AM Redaie, ...
    Saudi Journal for Health Sciences 7 (1), 28-32 , 2018
    2018
    Citations: 11
  • Formulation and evaluation of oral delivery systems for poorly absorbed drugs used in osteoporosis
    MM THOSAR
    dissertation] India: Gujarat Technological University , 2017
    2017
    Citations: 2

MOST CITED SCHOLAR PUBLICATIONS

  • Synthesis of 4-benzyl-1, 3-thiazole derivatives as potential anti-inflammatory agents: an analogue-based drug design approach
    RN Sharma, FP Xavier, KK Vasu, SC Chaturvedi, SS Pancholi
    Journal of enzyme inhibition and medicinal chemistry 24 (3), 890-897 , 2009
    2009
    Citations: 306
  • Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting
    A Paharia, AK Yadav, G Rai, SK Jain, SS Pancholi, GP Agrawal
    AAPS pharmscitech 8 (1), 12 , 2007
    2007
    Citations: 255
  • Synergistic antioxidant activity of green tea with some herbs
    DP Jain, SS Pancholi, R Patel
    Journal of advanced pharmaceutical technology & research 2 (3), 177-183 , 2011
    2011
    Citations: 179
  • Hydrotropic solubilization of nimesulide for parenteral administration
    S Agrawal, SS Pancholi, NK Jain, GP Agrawal
    International Journal of Pharmaceutics 274 (1-2), 149-155 , 2004
    2004
    Citations: 168
  • Pharmacognostic parameters for evaluation of the rhizomes of Curcuma caesia
    P Paliwal, SS Pancholi, RK Patel
    Journal of advanced pharmaceutical technology & research 2 (1), 56-61 , 2011
    2011
    Citations: 125
  • An overview on: Sublingual route for systemic drug delivery
    KP Nibha, SS Pancholi
    Intra-Oral Spray Technol 3, 1-103 , 2012
    2012
    Citations: 107
  • Asynchronous environment assessment: A pertinent option for medical and allied health profession education during the COVID-19 pandemic
    MM Gupta, S Jankie, SS Pancholi, D Talukdar, PK Sahu, B Sa
    Education Sciences 10 (12), 352 , 2020
    2020
    Citations: 93
  • Investigation of antimutagenic potential of Foeniculum vulgare essential oil on cyclophosphamide induced genotoxicity and oxidative stress in mice
    P Tripathi, R Tripathi, RK Patel, SS Pancholi
    Drug and Chemical Toxicology 36 (1), 35-41 , 2013
    2013
    Citations: 65
  • Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug
    MM Bandivadeka, SS Pancholi, R Kaul-Ghanekar, A Choudhari, ...
    Drug development and industrial pharmacy 38 (7), 883-892 , 2012
    2012
    Citations: 65
  • RP-HPLC-DAD method for determination of olmesartan medoxomil in bulk and tablets exposed to forced conditions
    RN Sharma, SS Pancholi
    Acta Pharmaceutica 60 (1), 13-24 , 2010
    2010
    Citations: 64
  • Surface-modified mesoporous ceramics as delivery vehicle for haemoglobin
    S Patil, SS Pancholi, S Agrawal, GP Agrawal
    Drug delivery 11 (3), 193-199 , 2004
    2004
    Citations: 54
  • Therapeutic potential of secoisolariciresinol diglucoside: a plant lignan
    D Patel, J Vaghasiya, SS Pancholi, A Paul
    International Journal of Pharmaceutical Sciences and Drug Research 4 (1), 15-18 , 2012
    2012
    Citations: 48
  • Preparation and characterization of reverse micelle based organogels of piroxicam
    GP Agrawal, M Juneja, S Agrawal, SK Jain, SS Pancholi
    Die Pharmazie-An International Journal of Pharmaceutical Sciences 59 (3 … , 2004
    2004
    Citations: 48
  • Single non-ionic surfactant based self-nanoemulsifying drug delivery systems: formulation, characterization, cytotoxicity and permeability enhancement study
    M Bandivadekar, S Pancholi, R Kaul-Ghanekar, A Choudhari, S Koppikar
    Drug Development and Industrial Pharmacy 39 (5), 696-703 , 2013
    2013
    Citations: 47
  • Simple RP-HPLC method for determination of triple drug combination of valsartan, amlodipine and hydrochlorothiazide in human plasma
    RN Sharma, SS Pancholi
    Acta Pharmaceutica 62 (1), 45-58 , 2012
    2012
    Citations: 44
  • Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery
    G Rai, SK Jain, S Agrawal, S Bhadra, SS Pancholi, GP Agrawal
    Die Pharmazie-An International Journal of Pharmaceutical Sciences 60 (2 … , 2005
    2005
    Citations: 41
  • Synthesis, characterization and evaluation of antimicrobial activity of a series of 1, 2, 4-triazoles
    R Agrawal, SS Pancholi
    Der Pharma Chemica 3 (6), 32-40 , 2011
    2011
    Citations: 40
  • Synthesis and biological evaluation of some 2-substituted derivatives of benzimidazoles
    SK Gupta, SS Pancholi, MK Gupta, D Agrawal, MP Khinchi
    J. Pharm. Sci. Res 2 (4), 228-231 , 2010
    2010
    Citations: 32
  • Oral iron chelators: A new avenue for the management of thalassemia major
    RN Sharma, SS Pancholi
    J. Curr. Pharm. Res 1, 1-7 , 2010
    2010
    Citations: 32
  • Comparative evaluation of some plant extracts on bronchoconstriction in experimental animals
    P Paliwal, SS Pancholi, RK Patel
    Asian J Pharm Life Sci 1 (1), 52-57 , 2011
    2011
    Citations: 30